Vertex Pharmaceuticals presented promising clinical data on their CFTR modulator ALYFTREK at the European Cystic Fibrosis Conference, showcasing improved outcomes for patients with reduced sweat ...

Mining company targets Q3 2025 for underground gold ore production. Vertex Minerals (ASX:VTX) is progressing with its Reward Gold Mine project in New South Wales, aiming for the first underground gold ...

The venture is projected to generate around €90 million in revenue by 2035. The consortium brings together 42 leading European technology companies from 13 countries to redefine how emergency ...

PROACTIF brings together notable partners across Europe including : Acorde Technologies, S.A. (Spain), AITEK SPA (Italy), Ascento AG (Switzerland), Asya SIA (Latvia), Avular Innovations B.V.

Vertex AI, and the Gemini app. Described as “better in nearly every dimension,” Gemini 2.5 Flash has been engineered to deliver the same high-quality outputs while being 22% more efficient ...

Eli Lilly is expanding its pain drug pipeline with the acquisition of SiteOne Therapeutics, a startup with a lead program that addresses the same target as a Vertex Pharmaceuticals product whose ...

Over the last two years, however, the company has seen an influx of interest and investment. That’s thanks, in good part, to the precedent set by Vertex Pharmaceuticals, which successfully developed ...

This will be the second funding for the Pune-based company in 2025. "Vertex Ventures is leading Rs 55 crore in Series A round at a post-money valuation of Rs 550 crore ($65 million)," said one of the ...